Aderans expands clinical trials.

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Mojo Risin
    Senior Member
    • Mar 2011
    • 157

    Aderans expands clinical trials.

    Aderans Research recently expanded its hair loss clinical trial to four new cities across the United States. With nearly 350 subjects to date, Aderans is undertaking one of the largest clinical studies ever designed to research cell-based solutions to pattern hair loss.

    “We continue to make good progress in our research and have a very positive outlook for the trial,” said Chief Executive Officer Ken Washenik, M.D., Ph.D. Plans are in order to finish Phase 2 next year and we’ll be one step closer to helping those who suffer from male and female pattern hair loss.”

    Launched in November 2008, Phase 2 is being conducted in 21 locations across the country. The newest sites to participate in the trial are Santa Rosa, Calif.; Greer, S.C.; Akron, Ohio; and Denver, Colo. Aderans continues to recruit subjects; visit http://www.aderansresearch.com/ari_clinicupdates.html for details about active locations.

    “Our cell engineering process is unlike any other,” said Vern Liebmann, Chief Operating Officer. “We’re focused on finding the most promising cell product treatment from the Ji Gami™ family of cell products. We are confident this holds the key to hair restoration.”

    A pioneer in its field, Aderans is committed to developing cutting-edge solutions for those who struggle with hair loss. For more information about Aderans Research, visit http://www.aderansresearch.com.

    ---------------------------------------

    Good enough.
  • UK Boy
    Senior Member
    • Apr 2011
    • 244

    #2
    2012?

    I read pretty much the same stuff and was pleased to hear that phase II was on track to finish next year. However I was reading a thread elsewhere and they had listed all the Aderans clinical trials, it shows that there was a trial that was started this July that doesn't conclude until Feb 2013. This is where I get confused and don't know if Aderans is just out right lying in there public statements or what. Because if that clinical trail which is part of the phase II trials doesn't conclude until Feb 2013 then how can they possibly be on track to wrap phase II up nexrt year!?

    Perhaps there's someone on here that knows more about it? This is the kind of situation where I wish these companies would give us more feedback, just to be totally clear on things.

    Comment

    • Mojo Risin
      Senior Member
      • Mar 2011
      • 157

      #3
      However I was reading a thread elsewhere

      Where.

      Comment

      • dkayla77
        Junior Member
        • Jul 2011
        • 13

        #4
        no he is right.

        there was a thread somewhere that had a link to the official clinicaltrials website or FDA trials website or something like that, and it listed all the aderans trials and one of them didn't end until february 2013.....they were testing various formulations.

        only thing i can think of is perhaps they have enough data or information to not need that last trial. otherwise, what can you say,they are probably making it up in public statements.

        Comment

        • Sogeking
          Senior Member
          • Feb 2011
          • 497

          #5
          I believe you guys are misreading something. By 'wrapping up' the phase II trials it means to get the first hand results 6 months after the adminstering their compound. But that doesn't mean they will stop there.
          I mean Histogen finished their phase I trials and showed their results but they still conducted post-op checkups after 1 year, and so on.

          To clarify:
          Adreans started the last part fo their phase II trial in July. 6 months later they will have first results, but due to efficacy and safety they still have one year follow up, second year follow up, etc.

          The same thing is with Replicel they will finish their phase I trials in February/March next year but they will still have follow up post_op checkups well into 2013. Thats how things are done. Because due to safety concerns your drug can start inducing potentially cancer viable compounds after a year or two, maybe even three of administering the compound.

          This is good news, but what it actually means is that Aderns is the least susceptible to financial problems. Although Replicels treatment seems more effective.

          But I believe that Aderns will be the first to come out with their treatment.

          Comment

          • Mojo Risin
            Senior Member
            • Mar 2011
            • 157

            #6
            Originally posted by dkayla77
            there was a thread somewhere
            I repeat : where.

            Comment

            • dkayla77
              Junior Member
              • Jul 2011
              • 13

              #7
              Originally posted by Mojo Risin
              I repeat : where.

              Comment

              • Kiwi
                Senior Member
                • Mar 2011
                • 1105

                #8
                Originally posted by Sogeking
                This is good news, but what it actually means is that Aderns is the least susceptible to financial problems. Although Replicels treatment seems more effective.

                But I believe that Aderns will be the first to come out with their treatment.
                What makes you "believe" that Replicel is more effective? Replicel have only just started testing on human beings so how the hell would any human being on this planet except maybe people in their inner circles know about this information.

                All we can say about Replicel is that it definitely grows hair on mice - really really well by the looks of it.

                Aderans on the other hand. Have over 350 balding people (not mice) growing hair back on their heads. We just don't know how well yet. I wish we did because I want to go out there and buy some!!!!

                All Aderans has to do for me is do a better job then Propecia. Then I reckon I could get a HT from anybody in the world to add density. If Gho works then Gho + Aderans could be the magic bullet we're all waiting for...

                Comment

                • RichardDawkins
                  Inactive
                  • Jan 2011
                  • 895

                  #9
                  Assumptions assumptions lets wait for 201 and then attack the companies

                  Comment

                  • Kiwi
                    Senior Member
                    • Mar 2011
                    • 1105

                    #10
                    Originally posted by RichardDawkins
                    Assumptions assumptions lets wait for 201 and then attack the companies
                    Exactly. We dont know anything just yet.

                    Also lets nobody attack anybody - we're all on the same side

                    Comment

                    • UK Boy
                      Senior Member
                      • Apr 2011
                      • 244

                      #11
                      [QUOTE=Sogeking;44755]I believe you guys are misreading something. By 'wrapping up' the phase II trials it means to get the first hand results 6 months after the adminstering their compound. But that doesn't mean they will stop there. I mean Histogen finished their phase I trials and showed their results but they still conducted post-op checkups after 1 year, and so on.

                      To clarify:
                      Adreans started the last part fo their phase II trial in July. 6 months later they will have first results, but due to efficacy and safety they still have one year follow up, second year follow up, etc.

                      I'm not gonna argue and I do understand totally what you're saying and maybe that is the case but my arguement is that they don't make that clear in their statement.

                      What they say is that they are on track to FINISH phase II next year, not gather information from the first 6 months before carrying on for another 2 years of follow ups. The presumption is that all parts of the trial will be finished and all information gathered so they can then move onto phase III. Replicel do not imply anywhere that their first phase will be FINISHED in Q1 2012, they simply say they will have the first info from it.

                      Once again, I'm not trying to get into an arguement, just simply saying that their statement seems misleading and I feel there's no need for it at the end of the day. All it's gonna mean is that next year people on the forums are gonna be going "Have Aderans finished their phase II yet, cos they said in their statement last year....." When in actual fact there may never have been any hope of them FINISHING phase II in 2012.

                      Comment

                      • Sogeking
                        Senior Member
                        • Feb 2011
                        • 497

                        #12
                        @UK Boy
                        Hey you might be right. Who knows how they've setup their trials.
                        All I'm saying it might be a difference of actual workings and proceedings of trials or semantics as I've proposed. We'll see in 2012, and than we can smite 'em .

                        @Kiwi
                        Honestly I don't care if it is Aderans, REplicel, Histogen or Redneck Bills HairCompany that offers us the most effective treatment. I just want one to come.
                        If both Aderans and Replicel offer theirs than more options for us which is a good thing!

                        What I am happy about is that atleast we have some promising stuff to watch for and hope for.
                        The situation is not so bright for acne remedies where there is no new treatments at all (just bunch of Trx2 types of differently packaged vitamins)
                        or for Alzhiemrs, cancer where there is constantly some new breakthrough in research coming out but no viable treatments to follow.

                        Comment

                        • RichardDawkins
                          Inactive
                          • Jan 2011
                          • 895

                          #13
                          I agree, i also dont give a **** who comes first or second as long as they come to market, thats it.

                          And i agree we baldies should consider ourselves lucky, we have viable options pretty soon, while as stated above people with acne Alzheimer desease, cancer, HIV dont have that good options.

                          And i can tell you, my skin is luckily pretty clean etc and i dont wanna have acne and a full head of hair, i rather have thinning hair and hm on the horizon and a solution to thinning hair rather then bad skin and good hair

                          Comment

                          • vamaqua
                            Junior Member
                            • Feb 2010
                            • 7

                            #14
                            I live in Denver and I am strongly considering enrolling in trials. Should I do it?

                            Comment

                            • fitness-man
                              Member
                              • May 2011
                              • 67

                              #15
                              Originally posted by vamaqua
                              I live in Denver and I am strongly considering enrolling in trials. Should I do it?
                              have you called to see what they are saying or asking?

                              Comment

                              Working...